Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age

New England Journal of Medicine

Volumn 297, Issue 13, 1977, Pages 686-691

  Peltola, Heikki ^a   Mäkelä, P Helena ^a   Käyhty, Helena ^a   Jousimies, Hannele ^a   Herva, Elja ^a   Hällström, Kalevi ^a   Sivonen, Aulikki ^a   Renkonen, Olli Veikko ^a   Pettay, Ossi ^a   Karanko, Viena ^a   Ahvonen, Paavo ^a   Sarna, Seppo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; CHILDHOOD; MENINGITIS; NEISSERIA MENINGITIDIS; PREVENTION; VACCINATION;

EID: 0017698226     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197709292971302     Document Type: Article

References (25)

1. Mäkelä PH, Käyhty H, Weckström P, et al: Effect of group A meningococcal vaccine in army recruits in Finland. Lancet 2: 883–886, 1975
2. Mihalcu F, Pasolescu O, Coban V, et al: Aspects actuels de la méningite cérébrospinale épidémique en Roumanie. Arch Roum Pathol Exp Microbiol 31: 125–134, 1972
3. Bormans J, Ureel D, Dachy A: Formes majeures de l'infection méningococcique et infections virales associées. Arch Belg Méd Soc 31: 403–410, 1973
4. WHO Study Group: Cerebrospinal meningitis control. WHO Tech Rep Ser 588: 1–29, 1976
5. Peltola H, Mäkelä PH, Elo O, et al: Vaccination against meningococcal group A disease in Finland 1974–75. Scand J Infect Dis 8: 169–174, 1976
6. Mäkelä PH, Peltola H, Käyhty H, et al: Field trial of meningoccoccal group A and Haemophilus influenzae type b polysaccharide vaccines in children. J Infect Dis (in press)
7. Anderson P, Peter G, Johnston RB Jr, et al: Immunization of humans with polyribophosphate, the capsular antigen of Hemophilus influenzae, type b. J Clin Invest 51: 39–44, 1972
8. Rodrigues LP, Schneerson R, Robbins JB: Immunity to Haemophilus influenzae type b. I. The isolation, and some physicochemical, serologic, and biologic properties of the capsular polysaccharide of Hemophilus influenzae type b. J Immunol 107: 1071–1089, 1971
9. Kuronen T, Peltola H, Nors T, et al: Adverse reactions and endotoxin content of polysaccharide vaccines. Dev Biol Stand 34: 117–125, 1977
10. Sivonen A, Renkonen OV, Robbins JB: Use of antiserum-agar plates for serogrouping of meningococci. J Clin Pathol (in press)
11. Leinonen M, Herva E: The latex agglutination test in the diagnosis of meningococcal and Haemophilus meningitis. Scand J Infect Dis (in press)
12. Käyhty H, Mäkelä PH, Ruoslahti E: Radioimmunoassay of capsular polysaccharide antigens of group A and group C meningococci and Haemophilus influenzae type b in cerebrospinal fluid. J Clin Pathol (in press)
13. Gold R, Winklehake JL, Mars RS, et al: Identification of an epidemic strain of group C Neisseria meningitidis by bactericidal serotyping. J Infect Dis 124: 593–597, 1971
14. Gästrin B, Kallings LO, Marcetic A: The survival time for different bacteria in various transport media. Acta Pathol Microbiol Scand 74: 371–380, 1968
15. Hornick RB, Woodward TE, McCrumb FR, et al: Typhoid fever vaccine — yes or no? Med Clin North Am 51: 617–623, 1967
16. MacLeod CM, Hodges RG, Heidelberger M, et al: Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides. J Exp Med 82: 445–465, 1945
17. Artenstein MS, Gold R, Zimmerly JG, et al: Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med 282: 417–420, 1970
18. Gotschlich EC, Goldschneider I, Artenstein MS: Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state. J Exp Med 129: 1385–1395, 1969
19. Lapeyssonnie L: La méningite cérébro-spinale en Afrique. Bull WHO 28: Suppl: 3–103, 1963
20. Gold R, Artenstein MS: Meningococcal infections. II. Field trial of group C meningococcal polysaccharide vaccine in 1969–70. Bull WHO 45: 279–282, 1971
21. Wahdan MH, Rizk F, El-Akkad AM, et al: A controlled field trial of a serogroup A meningococcal polysaccharide vaccine. Bull WHO 48: 667–673, 1973
22. Erwa HH, Haseeb MA, Idris AA, et al: A serogroup A meningococcal polysaccharide vaccine. Bull WHO 49: 301–305, 1973
23. Gold R, Lepow ML, Goldschneider J, et al: Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. J Clin Invest 56: 1536–1547, 1975
24. Goldschneider J, Lepow ML, Gotschlich EC, et al: Immunogenicity of group A and group C meningococcal polysaccharides in human infants. J Infect Dis 128: 769–776, 1973
25. Taunay A de E, Galvao PA, de Morais JS, et al: Disease prevention by meningococcal serogroup C polysaccharide vaccine in preschool children: results after eleven months in Sao Paulo, Brazil. Pediatr Res 8: 429, 1974